probiotics: Evidence Review
Probiotics, particularly those containing Lactobacillus and Bifidobacterium species, show potential in modulating glucose metabolism and inflammation in gestational diabetes mellitus (GDM) and improving symptoms in psoriasis. However, clinical trial results are inconsistent, necessitating further research to establish definitive protocols.
Quick Answer
Probiotics, particularly those containing Lactobacillus and Bifidobacterium species, show potential in modulating glucose metabolism and inflammation in gestational diabetes mellitus (GDM) and improving symptoms in psoriasis. However, clinical trial results are inconsistent, necessitating further research to establish definitive protocols.
Key Takeaways
- 01GDM affects approximately 14% of pregnancies worldwide, with probiotics potentially addressing gut dysbiosis and inflammation.
- 02Lactobacillus and Bifidobacterium species are the primary probiotics studied for GDM management.
- 03Probiotics may improve psoriasis symptoms by influencing gut microbiota and immune responses.
- 04Clinical evidence remains inconsistent, highlighting the need for more rigorous trials.
Quick Answer
Probiotics, particularly those containing Lactobacillus and Bifidobacterium species, show potential in modulating glucose metabolism and inflammation in gestational diabetes mellitus (GDM) and improving symptoms in psoriasis. However, clinical trial results are inconsistent, necessitating further research to establish definitive protocols.
Key Takeaways
- GDM affects approximately 14% of pregnancies worldwide, with probiotics potentially addressing gut dysbiosis and inflammation.
- Lactobacillus and Bifidobacterium species are the primary probiotics studied for GDM management.
- Probiotics may improve psoriasis symptoms by influencing gut microbiota and immune responses.
- Clinical evidence remains inconsistent, highlighting the need for more rigorous trials.
Clinical Evidence Deep-Dive
In the context of GDM, probiotics containing Lactobacillus and Bifidobacterium species have been investigated for their role in modulating gut microbiota. A scoping review by Uzair SA (2026) indicates that these probiotics could potentially reduce inflammation and improve insulin resistance, although the evidence from clinical trials remains inconsistent. The review highlights the need for larger sample sizes and standardized dosages to draw more reliable conclusions.
For psoriasis, an umbrella review by Ayuningtyas M (2026) examines the effectiveness of probiotics in alleviating symptoms. The review suggests a potential link between probiotic supplementation and improved gut microbiota, which may subsequently enhance immune parameters and reduce psoriasis symptoms. However, the findings across different studies vary, and further research is necessary to confirm these effects.
Practical Protocol
- GDM Management: Consider probiotic supplements containing Lactobacillus and Bifidobacterium species. Current evidence does not specify an optimal dosage, so clinicians should monitor patient responses and adjust accordingly.
- Psoriasis Treatment: Probiotic supplementation may be beneficial as an adjunct therapy. The specific strains and dosages require further investigation, so clinicians should proceed with moderate confidence and tailor recommendations to individual patient needs.
FAQ
What are the primary probiotics studied for GDM? Lactobacillus and Bifidobacterium species are the main probiotics studied for their potential benefits in managing gestational diabetes mellitus.
How do probiotics potentially benefit psoriasis patients? Probiotics may improve psoriasis symptoms by modulating gut microbiota and enhancing immune responses, although evidence is not yet definitive.
Are there standardized dosages for probiotics in these conditions? No standardized dosages have been established. Clinicians should monitor patient responses and adjust dosages as necessary.